Church & Dwight (NYSE:CHD) PT Lowered to $97.00 at JPMorgan Chase & Co.

Church & Dwight (NYSE:CHD) had its price target reduced by JPMorgan Chase & Co. from $98.00 to $97.00 in a research report released on Friday morning, Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the stock.

Other equities analysts also recently issued research reports about the stock. TheStreet raised shares of Church & Dwight from a c+ rating to a b rating in a report on Friday, February 2nd. Bank of America lifted their price objective on shares of Church & Dwight from $100.00 to $104.00 and gave the stock a neutral rating in a report on Monday, April 15th. Oppenheimer lifted their price objective on shares of Church & Dwight from $110.00 to $120.00 and gave the stock an outperform rating in a report on Tuesday, April 23rd. Stifel Nicolaus lifted their price objective on shares of Church & Dwight from $91.00 to $99.00 and gave the stock a hold rating in a report on Monday, February 5th. Finally, Truist Financial lifted their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a buy rating in a report on Friday. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of Hold and an average target price of $105.63.

Church & Dwight Trading Up 0.2 %

CHD opened at $106.11 on Friday. The firm has a market capitalization of $25.88 billion, a P/E ratio of 33.69, a P/E/G ratio of 3.55 and a beta of 0.51. The firm’s 50 day moving average is $103.68 and its 200-day moving average is $97.88. Church & Dwight has a 52-week low of $82.25 and a 52-week high of $108.68. The company has a quick ratio of 0.64, a current ratio of 1.33 and a debt-to-equity ratio of 0.54.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.10. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.49 billion. Church & Dwight had a net margin of 13.13% and a return on equity of 20.35%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.85 earnings per share. Analysts expect that Church & Dwight will post 3.46 EPS for the current fiscal year.

Church & Dwight Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Wednesday, May 15th will be paid a dividend of $0.2838 per share. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date of this dividend is Tuesday, May 14th. Church & Dwight’s dividend payout ratio is currently 35.87%.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Michael Read sold 4,500 shares of the business’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $105.00, for a total value of $472,500.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Church & Dwight news, EVP Michael Read sold 4,500 shares of the business’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $105.00, for a total value of $472,500.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Matthew Farrell sold 275,000 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $103.83, for a total transaction of $28,553,250.00. Following the completion of the sale, the chief executive officer now owns 112,719 shares in the company, valued at $11,703,613.77. The disclosure for this sale can be found here. Insiders have sold a total of 373,052 shares of company stock worth $38,603,796 over the last ninety days. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Church & Dwight

A number of institutional investors have recently bought and sold shares of CHD. JPMorgan Chase & Co. increased its stake in Church & Dwight by 89.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,027,312 shares of the company’s stock worth $552,283,000 after purchasing an additional 2,839,783 shares in the last quarter. Norges Bank acquired a new position in shares of Church & Dwight in the fourth quarter valued at $259,967,000. Capital International Investors grew its position in Church & Dwight by 39.2% in the fourth quarter. Capital International Investors now owns 9,004,713 shares of the company’s stock valued at $851,414,000 after acquiring an additional 2,533,877 shares during the period. Vanguard Group Inc. grew its position in Church & Dwight by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 30,265,072 shares of the company’s stock valued at $2,861,865,000 after acquiring an additional 354,946 shares during the period. Finally, Goldman Sachs Group Inc. grew its position in Church & Dwight by 26.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,334,950 shares of the company’s stock valued at $126,233,000 after acquiring an additional 277,017 shares during the period. Hedge funds and other institutional investors own 86.60% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.